RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
RxSight (Nasdaq: RXST) will host multiple Live Learning Sessions at AAO 2025 in Orlando, Oct 18–20, at Booth #2931. Sessions feature surgeons sharing real-world experience with the Light Adjustable Lens, focusing on clinical advantages and economic implications of adjustability.
Scheduled talks run Oct 18 (10:00 AM–3:00 PM) and Oct 19 (10:00 AM–1:00 PM) and cover topics such as ROI, career impact, premium lens adoption, patient-centered outcomes, and practical counseling for Light Adjustable Lens patients.
RxSight (Nasdaq: RXST) ospiterà multiple sessioni di Live Learning durante AAO 2025 a Orlando, dal 18 al 20 ottobre, allo stand #2931. Le sessioni vedranno chirurghi condividere esperienze reali con la Light Adjustable Lens, concentrandosi sui vantaggi clinici e sulle implicazioni economiche dell'adattabilità.
Gli interventi in programma si svolgeranno il 18 ottobre (10:00–15:00) e il 19 ottobre (10:00–13:00) e tratteranno temi quali ROI, impatto sulla carriera, adozione della lente premium, esiti centrati sul paziente e consulenza pratica per i pazienti della Light Adjustable Lens.
RxSight (Nasaq: RXST) organizará varias sesiones de aprendizaje en vivo en AAO 2025 en Orlando, del 18 al 20 de octubre, en el stand #2931. Las sesiones cuentan con cirujanos que comparten experiencias reales con la Light Adjustable Lens, enfocándose en las ventajas clínicas y las implicaciones económicas de la ajustabilidad.
Las charlas programadas se realizan el 18 de octubre (10:00–15:00) y el 19 de octubre (10:00–13:00) y abarcarán temas como ROI, impacto en la carrera, adopción de lentes premium, resultados centrados en el paciente y asesoramiento práctico para pacientes de Light Adjustable Lens.
RxSight (나스닥: RXST)가 올랜도에서 열리는 AAO 2025에서 10월 18–20일 부스 #2931에서 라이브 러닝 세션을 다수 개최합니다. 세션은 Light Adjustable Lens의 실전 경험을 수술 의사들이 공유하고 조절 가능성의 임상 이점과 경제적 함의를 다룹니다.
예정된 발표는 10월 18일 오전 10시–오후 3시, 10월 19일 오전 10시–오후 1시 사이에 진행되며 ROI, 경력 영향, 프리미엄 렌즈 채택, 환자 중심 결과 및 Light Adjustable Lens 환자를 위한 실질적인 상담과 같은 주제를 다룹니다.
RxSight (Bourse: Nasdaq RXST) organisera plusieurs sessions d'apprentissage en direct lors du AAO 2025 à Orlando, du 18 au 20 octobre, au stand #2931. Les sessions réuniront des chirurgiens partageant leur expérience réelle avec la Light Adjustable Lens, en mettant l'accent sur les avantages cliniques et les implications économiques de l'ajustabilité.
Les interventions prévues auront lieu le 18 octobre (10h00–15h00) et le 19 octobre (10h00–13h00) et aborderont des sujets tels que le ROI, l'impact sur la carrière, l'adoption de la lentille premium, les résultats centrés sur le patient et le conseil pratique pour les patients de la Light Adjustable Lens.
RxSight (Nasdaq: RXST) wird während des AAO 2025 in Orlando vom 18. bis 20. Oktober mehrere Live-Learning-Sitzungen am Stand #2931 abhalten. Die Sitzungen zeigen Chirurgen, die praktische Erfahrungen mit der Light Adjustable Lens teilen und sich auf klinische Vorteile und wirtschaftliche Auswirkungen der Einstellbarkeit konzentrieren.
Geplante Vorträge finden am 18. Oktober (10:00 Uhr–15:00 Uhr) und am 19. Oktober (10:00 Uhr–13:00 Uhr) statt und behandeln Themen wie ROI, Auswirkungen auf die Karriere, Einführung einer Premiumlinse, patientenzentrierte Ergebnisse sowie praktische Beratung für Light Adjustable Lens-Patienten.
RxSight (بورصة ناسداك: RXST) ستستضيف جلسات تعلم مباشرة متعددة في AAO 2025 في أورلاندو، من 18 إلى 20 أكتوبر، في الجناح #2931. تتضمن الجلسات أطباء جراحين يشاركون خبراتهم الواقعية مع Light Adjustable Lens، مع التركيز على المزايا السريرية والتبعات الاقتصادية لقابلية التعديل.
المحادثات المجدولة ستعقد في 18 أكتوبر (من 10:00 ص–3:00 م) وفي 19 أكتوبر (من 10:00 ص–1:00 م) وستشمل مواضيع مثل العائد على الاستثمار، تأثير المسار المهني، اعتماد العدسة المميزة، النتائج المركزة على المريض، وتوجيهات عملية للمرضى باستخدام Light Adjustable Lens.
RxSight (纳斯达克：RXST) 将在奥兰多的 AAO 2025 上举行多场现场学习会，10月18–20日，展位 #2931。会议由外科医生分享使用Light Adjustable Lens的实际经验，重点介绍可调性在临床上的优势及其经济影响。
计划的演讲在10月18日（10:00–15:00）和10月19日（10:00–13:00）举行，涵盖 ROI、职业影响、高端镜片的采用、以患者为中心的结果，以及面向 Light Adjustable Lens 患者的实际咨询等主题。
- None.
- None.
ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced it will be featured in multiple Live Learning Sessions at Booth #2931 during the American Academy of Ophthalmology Annual Meeting (AAO 2025), taking place October 18–20 at the Orange County Convention Center in Orlando, Fla.
This year’s Live Learning Sessions showcase real-world insights from leading surgeons who have incorporated the Light Adjustable Lens into their practices, highlighting the clinical advantages and the economic impact of adjustability.
LIVE LEARNING SESSIONS – RxSight Booth #2931
Saturday, October 18
10:00 AM – ROI You Can See with the Light Adjustable Lens
Taylor Strange, DO and Kasey Gantz – Alliance Vision Institute, Texas
11:00 AM – Jump Starting My Career with the Light Adjustable Lens
Brian Szabo, DO – Newsom Eye, Florida
12:00 PM – Locking in Clinical Confidence with the Light Adjustable Lens
Tanner Ferguson, MD – Vance Thompson Vision, South Dakota
1:00 PM – Accelerating Premium Lens Adoption with the Light Adjustable Lens
Matt Kaufman, MD – Eye Health Northwest, Oregon
2:00 PM – Who Really Benefits from the Light Adjustable Lens?
Eva Kim, MD – ICON Eyecare, Colorado
3:00 PM – Discovering Versatility with the Light Adjustable Lens
Quentin Allen, MD – Florida Vision Institute, Florida
Sunday, October 19
10:00 AM – Starting Strong with the Light Adjustable Lens
Alison Early, MD – Signature Cataract & Laser Consultants, Ohio
11:00 AM – Seeing Outcomes in a New Light with the Light Adjustable Lens
John Doane, MD – Discover Vision Centers, Kansas
12:00 PM – The Right Words for the Right Light Adjustable Lens Experience
Thomas Meirick, MD – Wolfe Eye Clinic, Iowa
1:00 PM – The Power of Adjustability: Patient-Centered Outcomes with the Light Adjustable Lens
John Josephson, MD – Eye Specialists and Surgeons of Northern Virginia, Virginia
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When and where will RxSight present Live Learning Sessions for RXST at AAO 2025?
What topics will RXST sessions cover about the Light Adjustable Lens at AAO 2025?
Which surgeons are speaking for RxSight (RXST) on Oct 18 at AAO 2025?
What is the schedule for RxSight (RXST) Live Learning Sessions on Oct 19 at AAO 2025?
How can ophthalmologists learn practical outcomes for the Light Adjustable Lens at RXST's AAO sessions?
Will RxSight (RXST) discuss the economic impact of the Light Adjustable Lens at AAO 2025?
